A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Clinical trial NCT00046072 · COMPLETED

Trial details

NCT number: NCT00046072
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Shock, Septic Sepsis Syndrome Septicemia Infection

Start date: 2001-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.